SIM
SRPT icon

Spark Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Spark Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,600
Closed -$1.13M – 241
2020
Q1 		$1.13M Sell
11,600
-7,900
-41% -$903K 0.6% 45
2019
Q4 		$2.52M Buy
+19,500
New +$1.97M 0.29% 103
2018
Q4 		– Sell
-23,600
Closed -$3.81M – 789
2018
Q3 		$3.81M Buy
23,600
+8,000
+51% +$1.09M 0.22% 146
2018
Q2 		$2.06M Buy
+15,600
New +$1.47M 0.12% 244
2017
Q1 		– Sell
-36,000
Closed -$987K – 885
2016
Q4 		$987K Buy
+36,000
New +$1.45M 0.08% 339

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Spark Investment Management's SRPT Position: Q2 2020 in Review

Spark Investment Management sold out of Sarepta Therapeutics (SRPT) in Q2 2020, closing a stake of 11,600 shares — an estimated $1.13M sold.

Spark Investment Management first reported a position in SRPT in Q4 2016 and held it in 5 quarters. The position peaked at $3.81M in Q3 2018. 408 funds tracked by Wall St. Rank hold SRPT as of Q2 2020.

  • Spark Investment Management reported no remaining Sarepta Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 11,600 Sarepta Therapeutics shares in Q2 2020, an estimated $1.13M.
  • Spark Investment Management first reported a position in Sarepta Therapeutics in Q4 2016 and held it in 5 quarters.
  • Spark Investment Management's Sarepta Therapeutics position peaked at $3.81M in Q3 2018.
  • 408 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.